U.S. Banks Stock News

NasdaqGM:PDYN
NasdaqGM:PDYNMachinery

A Look At Palladyne AI (PDYN) Valuation After 2026 Guidance And Backlog Expansion

Palladyne AI (PDYN) is back in focus after reporting Q4 and full year 2025 results, along with a fresh look at its 2026 outlook that combines earnings, guidance and backlog updates in one announcement. See our latest analysis for Palladyne AI. The latest earnings and guidance update landed after a sharp run in the shares, with a 7 day share price return of 21.34% and a 90 day share price return of 55.94% that point to building momentum despite a 14.36% pullback in the last session. The 3 year...
NYSE:PEB
NYSE:PEBHotel and Resort REITs

Pebblebrook’s Widening Annual Losses and Buybacks Might Change The Case For Investing In Pebblebrook Hotel Trust (PEB)

Pebblebrook Hotel Trust recently reported fourth-quarter 2025 results showing a small increase in sales to US$210.94 million and a lower net loss of US$17.85 million, while also confirming that full-year 2025 revenue edged up to US$1.48 billion despite a wider annual net loss of US$65.81 million. Alongside these results, the company issued guidance that still points to potential losses in 2026 and disclosed a significant share repurchase program in 2025, even as institutional interest...
NYSE:LUV
NYSE:LUVAirlines

Southwest Airlines (LUV) Valuation Check As Oil Shock And Macro Pressures Stir Investor Concerns

Southwest Airlines (LUV) is back in focus after a sharp escalation in the U.S., Israel, and Iran conflict pushed crude oil higher. This has raised fresh questions about jet fuel costs, margins, and stock volatility for the carrier. See our latest analysis for Southwest Airlines. At a share price of US$41.56, Southwest’s 1 day share price return of a 5.33% decline capped 7 day and 30 day share price returns of 15.63% and 23.41% declines. This comes even though the 90 day share price return of...
NYSE:APLE
NYSE:APLEHotel and Resort REITs

A Look At Apple Hospitality REIT (APLE) Valuation After Lower 2026 Net Income Guidance

Apple Hospitality REIT (APLE) is back in focus after reporting fourth quarter and full year 2025 results, alongside 2026 earnings guidance that points to lower expected net income compared with the prior year. See our latest analysis for Apple Hospitality REIT. The earnings release and lower 2026 net income guidance appear to have weighed on sentiment, with a 2.10% 1 day share price return decline to US$12.14 and a weaker 1 year total shareholder return of 10.38%. At the same time, the 90 day...
NYSE:TTAM
NYSE:TTAMBasic Materials

Titan America (TTAM) Valuation Check After Recent Pullback And Modest Undervaluation Narrative

Why Titan America Is On Investors’ Radar Titan America (TTAM) has drawn attention after a recent pullback, with the share price around $16.06. For investors, the key question is how this current level lines up with its fundamentals. See our latest analysis for Titan America. The recent pullback, including a 3.19% 1 day share price decline and 13.93% 30 day share price return, contrasts with Titan America’s 7.66% 1 year total shareholder return. This suggests near term momentum has cooled...
NYSE:RNST
NYSE:RNSTBanks

Earnings Beat, Dividend Hike and Insider Sale Could Be A Game Changer For Renasant (RNST)

In early March 2026, Renasant reported fourth-quarter 2025 results that beat analyst expectations, approved a US$0.23 per share quarterly dividend for payment on March 31, 2026, and disclosed an insider sale of 1,350 shares by EVP and Chief Accounting Officer Kelly Hutcheson. At the same time, investors grew more cautious about regional banks’ exposure to opaque private credit after a peer’s large loan write-off raised questions about hidden balance sheet risks across the sector. Against...
NYSE:DCO
NYSE:DCOAerospace & Defense

How Ducommun’s Profitability Rebound Amid a Full-Year Loss At Ducommun (DCO) Has Changed Its Investment Story

In late February 2026, Ducommun Incorporated reported fourth-quarter 2025 results showing sales of US$215.8 million and net income of US$7.44 million, while full-year 2025 sales rose to US$824.73 million alongside a net loss of US$33.94 million. The contrast between a profitable quarter and a loss-making year, with earnings per share swinging from US$2.13 to a US$2.27 loss, raises questions about what drove the weaker full-year performance beneath improving quarterly metrics. We’ll now...
NYSE:AL
NYSE:ALTrade Distributors

Assessing Air Lease (AL) Valuation After Strong Long Term Shareholder Returns

Why Air Lease Is On Investors’ Radar Today Air Lease (AL) is back in focus for investors after recent share price moves, with the stock last closing at US$64.52. That shift is prompting fresh attention on its fundamentals and recent return profile. See our latest analysis for Air Lease. While the 1-day and 7-day share price returns, at 0.14% and 0.49% declines respectively, suggest short term hesitation, Air Lease’s 1-year total shareholder return of 43.24% and 3-year total shareholder return...
NYSE:RLJ
NYSE:RLJHotel and Resort REITs

Did RLJ Lodging Trust’s (RLJ) 2025 EPS Collapse and Modest Buybacks Just Shift Its Investment Narrative?

In February 2026, RLJ Lodging Trust reported fourth quarter 2025 revenue of US$328.59 million and net income of US$0.43 million, alongside full-year 2025 revenue of US$1.35 billion and net income of US$28.51 million, both lower than the prior year. Despite completing a relatively small US$4.3 million share repurchase program covering 586,417 shares, the more striking development was the sharp fall in full-year earnings per share from continuing operations to US$0.01, highlighting pressure on...
NasdaqGM:WVE
NasdaqGM:WVEPharmaceuticals

Wave Life Sciences (WVE) Is Down 5.8% After Wider Losses And WVE-006 Accelerated Approval Push - What's Changed

Wave Life Sciences Ltd. reported fourth-quarter 2025 sales of US$17.24 million versus US$83.75 million a year earlier, with a net loss of US$53.18 million replacing prior net income, and full-year 2025 losses widening as revenues decreased. At the same time, Wave advanced its clinical and regulatory agenda by securing a late-breaking oral slot for WVE-006 at the American Thoracic Society conference and pursuing an accelerated approval pathway for alpha-1 antitrypsin deficiency, underscoring...
NasdaqGS:FFIV
NasdaqGS:FFIVCommunications

Does F5 (FFIV) Turning ARMOR AI Benchmarks Into Standards Reshape Its Security Moat?

In late February and early March 2026, F5, Inc. expanded support for World Wide Technology’s ARMOR AI security framework and launched new F5 Labs benchmarks, CASI and ARS, to help enterprises evaluate AI model security using CalypsoAI-derived threat intelligence. Together, these moves deepen F5’s role at the center of AI security architectures, linking its application delivery platform with standardized, research-backed measures of AI model risk. We’ll now examine how F5’s expanded role in...
NasdaqCM:PCT
NasdaqCM:PCTChemicals

How Investors Are Reacting To PureCycle Technologies (PCT) Auditor Going Concern Doubts And 2025 Losses

PureCycle Technologies reported full-year 2025 sales of US$8.36 million and a net loss of US$182.57 million, while its auditor, Grant Thornton, issued an unqualified opinion expressing doubt about the company’s ability to continue as a going concern in the 10-K filed on February 26, 2026. Alongside record fourth-quarter PureFive® rPP production and progress on its Antwerp expansion, PureCycle is planning a 30-day maintenance outage at its Ironton facility in 2026 and transitioning CFO...
NasdaqCM:WSC
NasdaqCM:WSCConstruction

A Look At WillScot Holdings (WSC) Valuation As Fencing And Security Offering Expands Nationwide

WillScot Holdings (WSC) recently made its fencing and perimeter security offering available nationwide, giving the company another way to support construction, event, and high risk sites alongside its modular and storage solutions. See our latest analysis for WillScot Holdings. Despite the fencing rollout, recent trading has been weak, with a 7 day share price return of 10.87% and a 30 day share price return of 13.48%. This has fed into a 1 year total shareholder return decline of 30.54%,...
NYSE:NSA
NYSE:NSASpecialized REITs

Assessing National Storage Affiliates Trust’s Valuation As Recent Share Price Momentum Returns

Why National Storage Affiliates Trust Is On Investors’ Radar National Storage Affiliates Trust (NSA) has drawn fresh attention after recent trading, with the stock closing at US$34.15. For income focused investors, the self storage REIT’s latest returns and fundamentals are back in focus. See our latest analysis for National Storage Affiliates Trust. The recent 1 day share price return of 0.47% and 30 day share price return of 4.5% sit within a stronger 90 day share price return of 15.65% and...
NYSE:TPR
NYSE:TPRLuxury

Is Tapestry (TPR) Quietly Rewriting Its Growth Story With Gen Z Momentum And Higher Guidance?

Tapestry recently reported past-quarter results showing revenue and non-GAAP EPS ahead of expectations, margin expansion, and raised full-year earnings guidance, supported by strong demand across key regions. A key driver was Coach’s success with younger shoppers, as Gen Z accounted for roughly one-third of 3.7 million new customers in the quarter, highlighting the brand’s growing resonance with emerging spenders. We’ll now examine how Tapestry’s stronger guidance and Gen Z customer momentum...
NYSE:GBTG
NYSE:GBTGHospitality

How Investors May Respond To GBTG Earnings Amid Efficiency Focus And Slower Two-Year Revenue Growth

Global Business Travel Group recently prepared to report quarterly earnings on 9 March 2026, following earlier disclosure of 12.9% revenue growth as of 30 September 2025 and muted 5.3% annual revenue expansion over the prior two years. Investors are particularly focused on how improved operating efficiency, relatively high servicing costs and cautious expectations might shape the company’s outlook and guidance. Against this backdrop of anticipated earnings and efficiency gains, we’ll examine...
NYSE:SO
NYSE:SOElectric Utilities

What Southern (SO)'s Analyst Upgrade Wave Means For Shareholders

In early March 2026, several research firms, including Evercore ISI and KeyBanc, raised their ratings on Southern Company, citing its capital investment plan, regulatory backdrop, and role as a large US electric and natural gas utility serving millions of customers. This cluster of upgrades signals a broad reassessment of Southern’s position within the utility sector, with analysts focusing on its long-term infrastructure build-out and exposure to growing electricity demand. We’ll now...
NasdaqGS:BTSG
NasdaqGS:BTSGHealthcare

How BrightSpring’s Big Equity Raise, Buyback Plan, and Earnings Beat Will Impact BrightSpring Health Services (BTSG) Investors

In early March 2026, BrightSpring Health Services completed a follow-on offering of 20,000,000 common shares for about US$822.72 million and simultaneously authorized a share repurchase program of up to US$60.00 million, alongside reporting strong fourth-quarter and full-year 2025 results and issuing revenue guidance of US$14.45 billion to US$15.00 billion for 2026. This combination of capital raising and targeted buybacks, together with higher revenues and a shift from a prior-year net loss...
NasdaqGS:UAL
NasdaqGS:UALAirlines

A Look At United Airlines (UAL) Valuation As Jet Fuel Shock Hits Earnings Outlook

United Airlines Holdings (UAL) is back in focus after CEO Scott Kirby warned that a sharp jump in jet fuel prices tied to the Iran conflict could meaningfully pressure first and possibly second quarter results. See our latest analysis for United Airlines Holdings. The stock’s recent weakness has been sharp, with a 1-day share price return of a 3.52% decline and a 30-day share price return of a 20.57% decline as fuel concerns intensified. However, the 5-year total shareholder return of 63.56%...
NasdaqGM:IOVA
NasdaqGM:IOVABiotechs

Is It Too Late To Reassess Iovance Biotherapeutics (IOVA) After Its Recent Share Price Surge

Wondering whether Iovance Biotherapeutics is priced attractively after its recent run, or if the easy money has already been made? This article focuses squarely on what the current share price might imply about value. The stock last closed at US$5.13, with returns of 32.9% over the past week, 102.8% over the past month, 103.6% year to date, and longer term returns of 36.8% over 1 year, 17.4% over 3 years, and 85.2% over 5 years. These moves have come alongside increased attention on Iovance...
NasdaqCM:IMTX
NasdaqCM:IMTXBiotechs

Assessing Immatics (NasdaqCM:IMTX) Valuation After Earnings Loss And Pipeline And Moderna Updates

Earnings Loss Puts Immatics in Focus Immatics (NasdaqCM:IMTX) is back on investors’ radar after reporting a full year 2025 net loss of €196.45 million and a basic loss per share of €1.61 from continuing operations. This earnings update comes alongside progress in its PRAME focused cell and bispecific therapies, ongoing Phase 3 work for anzu cel, and a collaboration with Moderna that recently triggered a milestone payment. See our latest analysis for Immatics. At a share price of US$9.86,...
NYSE:LNG
NYSE:LNGOil and Gas

Is Cheniere Energy (LNG) Pricing In Its Rapid Share Price Run And LNG Role

If you are wondering whether Cheniere Energy's share price reflects its true value, this article walks through what the current market price might be implying about the business. The stock recently closed at US$255.15, with returns of 8.2% over 7 days, 19.7% over 30 days, 29.0% year to date, 17.0% over 1 year, 70.4% over 3 years and 255.3% over 5 years. Recent coverage has focused on Cheniere Energy's role as a major US liquefied natural gas exporter and how global energy supply...
NasdaqCM:CORT
NasdaqCM:CORTPharmaceuticals

Why Corcept Therapeutics (CORT) Is Down 5.1% After FDA Relacorilant Rejection And Lower 2025 Earnings

Corcept Therapeutics reported fourth-quarter 2025 net income of US$24.29 million and full-year net income of US$99.65 million, both lower than the prior year, while also issuing 2026 net revenue guidance of US$900 million to US$1.00 billion. These results arrived as the company is contending with an FDA Complete Response Letter rejecting relacorilant’s approval and a series of securities class action lawsuits alleging it misled investors about the drug’s regulatory outlook. We’ll now examine...
NasdaqGS:CORZ
NasdaqGS:CORZSoftware

Core Scientific (CORZ) Valuation Check As AI Data Center Pivot And US$500 Million Loan Reshape The Story

Core Scientific (CORZ) is in the spotlight after securing a US$500 million, 364 day loan facility from Morgan Stanley, with potential expansion to US$1 billion, to fund its AI focused data center push. See our latest analysis for Core Scientific. The new loan comes on the heels of Core Scientific’s Q4 2025 earnings release, which included lower annual revenue, a financial restatement tied to internal control issues, and plans to sell most of its bitcoin holdings as it tilts further toward AI...